Biphenyl

Biphenyl

SCHEMBL7217541

CC(C)n1cccc1.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
CYP17A1 P05093 7/20 0.43
PTGS2 P35354 1/20 0.39
SLC6A4 P31645 2/20 0.37
SLC22A2 O15244 1/20 0.37
SLC22A1 O15245 1/20 0.37
SLC22A3 O75751 1/20 0.37
KMT2A Q03164 2/20 0.37
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
TSHR P16473 1/20 0.36
MEN1 O00255 1/20 0.36
NR1I2 O75469 1/20 0.36
USP2 O75604 1/20 0.36
ABCB11 O95342 1/20 0.36
PLA2G1B P04054 1/20 0.36
TP53 P04637 1/20 0.36
PGR P06401 1/20 0.36
HSP90AA1 P07900 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1091555 0.81
Biphenyl SCHEMBL27656690 0.74 ALDH1A1 (0.69) ALDH1A1PTGS2SLC6A4SLC22A2SLC22A1
Biphenyl SCHEMBL27519887 0.72 ALDH1A1 (0.64) ALDH1A1PTGS2SLC6A4SLC22A2SLC22A1
SCHEMBL12770874 0.70 CYP2D6 (0.54) ALDH1A1CYP17A1KMT2AHPGDNPSR1
SCHEMBL7009772 0.70 CYP2D6 (0.54) ALDH1A1CYP17A1KMT2AHPGDNPSR1
Biphenyl SCHEMBL23270851 0.69 ALDH1A1 (0.60) ALDH1A1PTGS2SLC6A4SLC22A2SLC22A1
Biphenyl SCHEMBL9503944 0.69 ALDH1A1 (0.60) ALDH1A1PTGS2SLC6A4SLC22A2SLC22A1
Biphenyl SCHEMBL8391913 0.69 ALDH1A1 (0.60) ALDH1A1PTGS2SLC6A4SLC22A2SLC22A1
Biphenyl SCHEMBL11779724 0.69 ALDH1A1 (0.60) ALDH1A1PTGS2SLC6A4SLC22A2SLC22A1
Biphenyl SCHEMBL3105248 0.69 ALDH1A1 (0.60) ALDH1A1PTGS2SLC6A4SLC22A2SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6590119-B2 Catalytic alcoholysis of benzoylcyclohexanone ketals; products useful as intermediates for diarylpyrrole therapeutic agents ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-07-08 US disclosed
US-20020107408-A1 Methods for the synthesis of dioxoalkanoic acid compounds FERRO MICHAEL P (US) 2002-08-08 US disclosed
US-6355812-B1 ALCOHOLYSIS OF BENZOYLCYCLOHEXANONE KETAL COMPOUNDS ORTH-MCNEIL PHARMACEUTICAL, INC. 2002-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107408-A1 Methods for the synthesis of dioxoalkanoic acid compounds DCK, DDT, AOX1 ALDH1A1 281/4885CYP17A1 111/4885PTGS2 1154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.